Question 1

What is EyePoint's mission?

Accepted Answer

EyePoint is committed to developing therapeutics to improve the lives of patients with serious retinal diseases, with a focus on science and innovation to offer a lifetime of clearer vision.

Question 2

What is EyePoint's core technology?

Accepted Answer

EyePoint's proprietary and proven Durasert™ technology enables the potential to preserve vision with less burden, as it has been safely administered to thousands of patients' eyes across four FDA-approved products.

Question 3

What is EyePoint's lead product candidate?

Accepted Answer

EyePoint's lead product candidate is Duravyu™, which combines a patent-protected tyrosine kinase inhibitor, vorolanib, formulated in the proprietary bio-erodible Durasert™ technology for sustained intraocular delivery.

Question 4

What is the current status of Duravyu™?

Accepted Answer

Duravyu™ is an investigational product that has been conditionally accepted by the FDA as the proprietary name for EYP-

Question 5

What is the company's approach to developing treatments for retinal diseases?

Accepted Answer

EyePoint is driven to improve vision by developing and commercializing innovative therapeutics, with a clear focus on its retinal disease-focused pipeline that leverages its proprietary Durasert™ technology to potentially preserve vision with less burden for patients.

EyePoint Pharmaceuticals, Inc.

Company Overview

Company Name

Address

Website

Employees

Established

About EyePoint Pharmaceuticals, Inc.

Frequently Asked Questions about EyePoint Pharmaceuticals, Inc.

What is EyePoint's mission?

What is EyePoint's core technology?

What is EyePoint's lead product candidate?

What is the current status of Duravyu™?

What is the company's approach to developing treatments for retinal diseases?

Technologies Used

Social Profiles

Key Decision Makers